TFS’s Expertise in Oncology

TFS is Your Global Oncology CRO Partner

Looking for an experienced oncology CRO to support your clinical trial? TFS HealthScience is a global, full-service contract research organization with a strong track record in delivering successful oncology and hematology studies.

With over 300 oncology and hematology clinical trials completed in 17+ countries, TFS offers the therapeutic expertise, global reach, and operational excellence you need to accelerate your study. Our specialized operations teams and medical advisors are dedicated to advancing oncology research with cutting-edge approaches—from CAR-T and biomarker-driven studies to adaptive trial designs and radiopharmaceutical innovations.

Download the reference sheet to:

  • See our breadth of experience across key oncology and hematologic indications
  • Explore our capabilities in cell and gene therapies, immuno-oncology, and more
  • Understand how TFS supports your success from early- to late-phase trials

Download our reference sheet now to see how TFS brings scientific insight, operational precision, and global execution to oncology clinical trials.

Learn more about our related services and resources:

TFS Oncology & Hematology

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology Expertise

Ophthalmology
The blind spot in ophthalmology trials: Patients who cannot feel their disease progressingArticle

The blind spot in ophthalmology trials: Patients who cannot feel their disease progressing

Building retention into trial design from day one can improve study performance. Learn key considerations for ophthalmology research teams.
Sarcoma
Up to 1 in 3 sarcoma diagnoses change on second reviewArticle

Up to 1 in 3 sarcoma diagnoses change on second review

TFS HealthScience on what sponsors should ask before a sarcoma programme begins and how we build protocols around real clinical practice.
The new endpoints reshaping oncology trial designWebinars

The new endpoints reshaping oncology trial design

The endpoint and eligibility shifts reshaping oncology trial design in 2026. Watch the full replay or download the slides.